Menin, a known tumor-suppressor gene in endocrine glands, has been associated with germline mutations causing multiple endocrine neoplasia type 1 (MEN1) syndrome as well as driving leukemogenesis in leukemia characterized by the rearrangement of the KMT2A gene [19]. Here, MEN1 is linked to multiple endocrine neoplasia type 1.